trefoil factor 3 protein (TFF3) / The GI Company - LARVOL DELTA

PROBAN: The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia (clinicaltrials.gov) - P=N/A; N=147; Recruiting; Sponsor: University of Cambridge; Not yet recruiting ➔ Recruiting

Biomarker • Clinical • Enrollment open • Barrett Esophagus • Esophageal Cancer • Gastrointestinal Cancer • Oncology

Oral and Systemic Levels of TFF-1 and TTF-3 in Periodontal Diseases (clinicaltrials.gov) - P; N=100; Completed; Sponsor: Aydin Adnan Menderes University

New trial • Dental Disorders • Periodontitis

The Value of TFF3 in Diagnosis of Gastric Cancer (clinicaltrials.gov) - P=N/A; N=90; Recruiting; Sponsor: Assiut University; Trial completion date: Nov 2020 ➔ Nov 2022; Initiation date: Jul 2019 ➔ Nov 2020; Trial primary completion date: Jul 2020 ➔ Nov 2021

Trial completion date • Trial initiation date • Trial primary completion date • TFF3

PROBAN: The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia (clinicaltrials.gov) - P=N/A; N=147; Not yet recruiting; Sponsor: University of Cambridge

Biomarker • Clinical • New trial

The Value of TFF3 in Diagnosis of Gastric Cancer (clinicaltrials.gov) - P; N=90; Recruiting; Sponsor: Assiut University

New trial

Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers (clinicaltrials.gov) - P=N/A; N=171; Active, not recruiting; Sponsor: Ilker Kahramanoglu; Recruiting ➔ Active, not recruiting; Trial completion date: Apr 2018 ➔ May 2019; Trial primary completion date: Jan 2018 ➔ Jun 2018

Biomarker • Enrollment closed • Trial completion date • Trial primary completion date